Skip to content
Medical Health Aged Care, Seniors Interest

Being embedded and on-site enhances pharmacists’ quality use of medicines activities at aged care facilities

Monash University 2 mins read
Aged care pharmacy, supplied by Monash

A new study by Monash University suggests being on-site and truly embedded within the interprofessional aged care team provides greater opportunities to support resident- and system-level improvements in quality use of medications. 

In 2022 the Australian Government announced a national rollout of embedded on-site pharmacists in all Government funded residential aged care facilities (RACFs). This was in direct response to recommendations from the 2019 Royal Commission into Aged Care Quality and Safety, and builds on evidence from national and international studies. While the details of the model are yet to be finalised, it is anticipated that the phased roll-out of this new workforce model will now commence in 2024. 

The new study by the Centre for Medicine Use and Safety (CMUS) at the Monash Institute of Pharmaceutical Sciences (MIPS) and published in the Australasian Journal on Ageing, set out to explore the roles of early adopters of Australia’s embedded on-site pharmacist model in supporting quality use of medications in RACFs.

Lead author Dr Amanda Cross, a pharmacist and Research Fellow at CMUS, interviewed 15 pharmacists from around Australia who were early adopters of the embedded onsite aged care pharmacist model. 

“It was evident from the early adopters of this model that being embedded and onsite was important for being able to be an advocate for the resident, build enhanced relationships with the interdisciplinary team, and drive system-level improvements in medication management,” Dr Cross said.

The study highlights both resident-level roles (e.g. actively contributing to collaborative outcome-focused resident-centred care) and system-level roles (e.g. leading clinical governance and quality improvement processes). The system-level roles were consistent with that of a knowledge broker, an individual who helps to move evidence and guidelines into local practice. 

Dr Cross says, “This system-level knowledge broker role can serve as a framework to help guide the new aged care pharmacist model. Pharmacists acting as knowledge brokers can help to improve policies and processes, link key stakeholders and build the capacity of individuals and the aged care provider organisations to support quality use of medications.” 

Dr Cross and colleagues at CMUS are currently working on two Medical Research Future Fund projects investigating the role of embedded on-site pharmacists working as knowledge brokers in residential aged care. This includes implementing the new CMUS-led Australian Clinical Practice Guidelines for the Appropriate Use of Psychotropic Medications in People Living with Dementia and in Residential Aged Care. 

CMUS Director Professor Simon Bell said “the study provides important insights into new resident- and system-level roles for pharmacists and the corresponding competencies that will be required.” 

The full paper has been published in the Australasian Journal on Ageing and can be read here   


Contact details:

Kate Carthew - Media and Communications Manager
T: +61 (0) 438 674 814


More from this category

  • Medical Health Aged Care, Science
  • 19/04/2024
  • 15:00
Monash University

Large-scale genetic study finds new link between Irritable Bowel Syndrome and the cardiovascular system

New research published today in the journal Cellular and Molecular Gastroenterology and Hepatology sheds light on disease mechanisms common to irritable bowel syndrome (IBS) and cardiovascular diseases (CVD). Led by Dr Leticia Camargo Tavares, a Postdoctoral Fellow at the Hypertension Research Laboratory within Monash University’s School of Biological Sciences, the study reveals novel insights into the genetic underpinnings of IBS, offering potential avenues for therapeutic intervention. IBS is one of the most prevalent gastrointestinal disorders globally, affecting up to 10 per cent of the population, with a disproportionate impact on women. It is characterised by a complex range of symptoms…

  • Medical Health Aged Care
  • 19/04/2024
  • 11:13
Gilead Sciences Australia

Australian community organisations addressing viral hepatitis receive AU$400,000 via global Gilead ALL4LIVER Grant program

– Gilead Sciences joins forces with World Hepatitis Alliance and experts to drive progress on viral hepatitis elimination targets – – Australian initiatives well represented in Gilead’s US$4 million global fund to empower local communities in the fight against viral hepatitis – Melbourne, Australia, 19 April 2024 – Today, on World Liver Day, Gilead Sciences Australia has announced nine local community organisations addressing viral hepatitis will receive a combined AU$400,000 via the global Gilead ALL4LIVER Grant. The recipients were selected by an independent external review panel of global experts, including the World Hepatitis Alliance. Australia has committed to achieving the…

  • Contains:
  • Medical Health Aged Care
  • 19/04/2024
  • 08:15
Royal Australian College of GPs

“Give us a break”: GPs call for key improvements to the Hospital in the Home program

The Royal Australian College of GPs (RACGP) is urging the federal Government to help GPs and patients take full advantage of the Hospital in the Home program. It comes following College President, Dr Nicole Higgins, writing to the Minister for Health and Aged Care, Mark Butler, calling for action. Under Hospital in the Home, patients receive acute care in the comfort of their home, or another suitable location. RACGP President Dr Nicole Higgins called for change. “Inconsistent guidance, billing confusion and communication issues are a headache for GPs and patients. These issues are holding back the Hospital in the Home…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.